ANAGENICS LIMITED — Director's Dealing 2017

Mar 15, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Cellmid Limited
ABN	69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Ms Maria Halasz
Date of last notice	18 January 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	10-16 March 2017
No. of securities held prior to change	Direct - 2,850,000 fully paid ordinary shares - 12,000,000 fully paid ordinary (loan) shares Indirect - 12,458,225 fully paid ordinary shares - 5,000,000 unlisted options (expiry 15/6/2017 exercise price $0.032)

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class			(a) Fully paid ordinary shares – On Market Trade	(a) Fully paid ordinary shares – On Market Trade
Number acquired	er acquired		(a) 400,000
Value Note: I valuatio	/Consideration f consideration is non-cash, provide details and estimated n		(a) $11,600
No. of securities held after change
	securities held after change		Direct - 3,250,000 fully fll	paid ordinary shares id di l h
			- 12,000,000 uy Indirect	pa ornary (oan) sares
			- 12,458,225 fully paid ordinary shares - 5,000,000 unlisted options (expiry 15/6/2017 exercise price $0.032)
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back			On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3